Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposomes for thoracic paravertebral block after thoracoscopic lung resection
ChiCTR2400087650Phase 4Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Jul 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine and bupivacaine in postoperative pain and Persistent postsurgical pain (PPSP) (2 arms), sponsored by Tangdu Hospital. Primary endpoint: Incidence of chronic pain three months after surgery. Started Jul 2024; status: recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative painPersistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ChiCTR2400087650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087650.